Abraham AA, John TD, Keller MD, et al. Safety and feasibility of virus-specific T cells derived from umbilical cord blood in cord blood transplant recipients. Blood Adv. 2019;3(14):2057-2068
- PMID: 31420368
- PMCID: PMC6712523
- DOI: 10.1182/bloodadvances.2019000741
Abraham AA, John TD, Keller MD, et al. Safety and feasibility of virus-specific T cells derived from umbilical cord blood in cord blood transplant recipients. Blood Adv. 2019;3(14):2057-2068
Erratum for
-
Safety and feasibility of virus-specific T cells derived from umbilical cord blood in cord blood transplant recipients.Blood Adv. 2019 Jul 23;3(14):2057-2068. doi: 10.1182/bloodadvances.2019000201. Blood Adv. 2019. PMID: 31292125 Free PMC article.
